Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10753 - 10760 of 11616 results
Mayor Bloomberg Vetoes Legislation Prohibiting Discrimination Against Unemployed
February 25, 2013| Blog| Viewpoint
Ninth Circuit Clarifies Extraterritorial Reach of California Antitrust Laws
February 25, 2013| Alert| Viewpoint
Energy & Clean Tech Connections: Your Law Firm Link to Industry News
February 22, 2013| Article| Viewpoint
Supreme Court Unanimously Rules Unforeseeability Bars Immunity Defense for Allegedly Anticompetitive Hospital Merger
February 21, 2013| Advisory| Viewpoint
Sequestration: Responding to Government Contract Delays and Changes
February 20, 2013| Alert| Viewpoint
AMR Decision Highlights Bankruptcy Court Split on Enforceability of Ipso Facto Clauses
February 20, 2013| Blog| Viewpoint
Mintz Ranked in Top Ten by LMG Clean Technology and Renewable Energy
February 19, 2013| Blog| Viewpoint
The New HIPAA Omnibus Rule & Your Liability -- A Detailed Review
February 17, 2013| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.
Events
Podcasts
The ‘Third Inning’ of the Energy Transition
December 6, 2024| Podcast|
Mintz on Air - Predictions and Practical Policies
November 25, 2024| Podcast|